Fig. 3. Effects of VEGF-A₁₆₄ antibody (ab, 5 μg) injected subcutaneously on formalin-induced nociceptive behavior. Subcutaneous administration of VEGF-A₁₆₄ antibody did not affect formalin-induced nociceptive behavior. There were six animals in each group.

Oral Biol Res 2023;47:151~158 https://doi.org/10.21851/obr.47.04.202312.151

© Oral Biol Res